SAA1 and osteoporosis: Corticosteroids, such as methylprednisolone (Medrol), are commonly used for symptomatic relief and inflammation control but are not the preferred long-term option due to their limited effect on SAA production and potential complications such as osteoporosis and metabolic disturbances [32].